Home
About Us
Core Team
Development History
Corporate Culture
S&T
Research Areas
Technology Platforms
Research and Development
Marketed Products
R&D Products
R&D Pipeline
Academic Progress
Blog
Company News
Media Reports
Join Us
Post-Doctoral Center
Contact Us
[Shengsheng Case Study] Issue 310: A Case Study on Nilotinib Treatment for Tonsillar Cancer
View details
→
[Breaking News] Long-term Follow-up Results of a Randomized Phase III Study Comparing Nivolumab Plus Chemoradiotherapy to Chemoradiotherapy Alone for Locally Advanced Head and Neck Squamous Cell Carcinoma
[Breaking News] ASCO Annual Meeting Unveils Three Studies on Nivolumab Combined with Concurrent Chemoradiotherapy for Locally Advanced Cervical Squamous Cell Carcinoma
[Case of Xingsheng] Issue 309: Case Study on Nilotinib Treatment for Tongue Squamous Cell Carcinoma
Biotech Pharma participates in the "YiQi Cup" 2024 Economic Development Zone Foreign-Invested Enterprises Staff Table Tennis Tournament
[Breaking News] ASCO Annual Meeting Announces Study on Nivolumab Plus Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Cancer